Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul 10;12(7):2056.
doi: 10.3390/nu12072056.

Diet and Nutraceutical Supplementation in Dyslipidemic Patients: First Results of an Italian Single Center Real-World Retrospective Analysis

Affiliations

Diet and Nutraceutical Supplementation in Dyslipidemic Patients: First Results of an Italian Single Center Real-World Retrospective Analysis

Andrea Pasta et al. Nutrients. .

Abstract

Background: Dyslipidemias are a heterogeneous group of metabolic disorders mainly characterized by an increased risk of atherosclerotic cardiovascular disease (ASCVD) or other conditions, such as acute pancreatitis in hypertriglyceridemia. The aim of this study was to evaluate the effect of diet treatment and nutraceutical (NUTs) supplementation on the plasma lipid profile in outpatient dyslipidemic subjects, considering the influence of several factors (i.e., gender, age, body mass index, alcohol consumption, and smoking habits).

Methods: 487 dyslipidemic patients spanning from 2015 to 2019 were treated with a Mediterranean diet or NUTs in a real-word setting and were retrospectively analyzed. General characteristics and lipid profile at baseline and after the follow-up period were evaluated.

Results: Diet alone reduced total cholesterol (-19 mg/dL, -7.7%), LDL cholesterol (-18 mg/dL, -10.1%), and triglycerides (-20 mg/dL, -16.7%). Triglycerides (TG) decreased more in men, while women were associated with higher reduction of LDL cholesterol (LDL-C). Different types of NUTs further ameliorate lipid profiles when associated with diet. Nevertheless, most patients at low ASCVD risk (222 out of 262, 81.6%) did not achieve the 2019 ESC/EAS guidelines recommended LDL-C goals (i.e., LDL-C < 116 mg/dL).

Conclusion: Lipid-lowering diet improves lipid profile, and NUTs can boost its efficacy, but taken together they are mainly unsatisfactory with respect to the targets imposed by 2019 EAS/ESC guidelines.

Keywords: EAS/ESC guidelines LDL-C targets; dyslipidemias; hypercholesterolemia; hypertriglyceridemia; lipid lowering diet; nutraceutical supplements.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flow chart of study design and allocation criteria and grouping for patients’ former analysis.
Figure 2
Figure 2
Percentage variation of lipid parameters in different NUTs groups.

References

    1. Yu J.N., Cunningham J.A., Thouin S.R., Gurvich T., Liu D. Hyperlipidemia. Prim. Care. 2000;27:541–587. doi: 10.1016/S0095-4543(05)70164-0. - DOI - PubMed
    1. Nelson R.H. Hyperlipidemia as a Risk Factor for Cardiovascular Disease. Prim. Care. 2013;40:195–211. doi: 10.1016/j.pop.2012.11.003. - DOI - PMC - PubMed
    1. Roy S. Atherosclerotic Cardiovascular Disease Risk and Evidence-based Management of Cholesterol. N Am. J. Med. Sci. 2014;6:191–198. doi: 10.4103/1947-2714.132916. - DOI - PMC - PubMed
    1. Cabezas M.C., Burggraaf B., Klop B. Dyslipidemias in clinical practice. Clin. Chim. Acta. 2018;487:117–125. doi: 10.1016/j.cca.2018.09.010. - DOI - PubMed
    1. Scherer J., Singh V.P., Pitchumoni C.S., Yadav D. Issues in hypertriglyceridemic pancreatitis: An update. J. Clin. Gastroenterol. 2014;48:195–203. doi: 10.1097/01.mcg.0000436438.60145.5a. - DOI - PMC - PubMed

MeSH terms